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Abstract

Introduction

A protein extracted from a urate - calcium oxalate
stone by electrodialysis is also excreted in the urine
which served as the source material for its purification
by FPLC after separation on an ACA44 column. It has
an amino acid composition appropriate for a cationic
protein.
One peptide obtained by cyanogen bromide
cleavage has significant (approximately 60 %) homology
with CD59 protein (protectin). Both proteins have wide
distribution, the unknown having been found in bile,
cholesterol
gallstones, and the wall of the aorta.
However, the two proteins appear to be immunologically
different.

Many proteins have been identified in renal stones
since the pioneering work of Boyce et al. [2]. Some,
like albumin and transferrin, are components of serum
and urine, some are present in urine but absent or barely
detectable in serum such as the Tamm Horsfall [3] protein and nephrocalcin [5], others have been extracted but
not characterized and remain to be identified. This last
group of proteins may be of special interest for their
likely selective incorporation into stones would suggest
an important role in the early events of stone formation.
In order to study these early events in vitro, it is necessary to isolate and purify these proteins with minimal alteration of their native state. In this paper we report the
purification and characterization of such a protein originally extracted from a urate-calcium oxalate renal stone
and subsequently from urine.

Materials and Methods
This urate-calcium oxalate stone, the original
source of the protein, was extracted as previously described by electrodialysis [l] in the ISCO apparatus and
part of the extract served to develop an antiserum in the
rabbit. This antiserum was used to scan concentrated
urine and other extracts by immunodiffusion in agar. A
urinary protein with reaction of identity with one of the
stone proteins was detected, thus providing an unlimited
quantity of material to isolate and purify the protein as
follows: the urine is concentrated by dialysis against
polyethylene glycol [PEG] and the proteins are precipitated by a finer PEG [molecular weight (M.W.) = 3,500
Dal tons (D)] at a final concentration of 20%. The PEG
is separated from the protein solution by the addition of
1 M sodium sulfate [4] and the lower phase is carefully
removed and dialyzed in the cold room against large volumes of reverse osmosis distilled water for a minimum
of 24 hours. The specimen is then concentrated against
PEG and centrifuged in a refrigerated centrifuge. It is
applied to a column (AcA44-Ultrogel-IBF,
10-130 kD
M.W.) and the protein fractions eluted with 0.09 M
Tris-Glycine buffer pH 8.2 at 4 °C. The void volume is
measured and the eluate is divided into three fractions
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Fig. 1 a
Figure la (above). SDS-PAGE electrophoresis. a and b represent 30 µl aliquots
of the purified protein; c = 50 µI. The concentration of the specimen is 2 mg/ml.
The stain is Coomassie.
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Figure lb (at right).
Molecular weight standard from 20-92 kD; the
concentration of unknown is 3-4 mg/ml and the quantity 40 µI. The stain is
Coomassie.
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Figure 2a (at left). Isoelectric focusing. Lanes l and
6 represent the purified protein which has an isoelectric
point of 8.4; lanes 2 and 3 represent gallbladder stone
extracts; 4 and 5 kidney stone extracts, and 7 is the
standard on the far right with isoelectric point of 3 to
10. The samples are 5 µ1; the standard 1 µI. The sample concentration is approximately 2 mg/ml; the standard
concentration = 0.01 mglµl.

Figure 3 (above). Immuno-dot of the purified protein.
a, b and c represent an 0.1 µl aliquot applied 5, 3 and 2
times, respectively, to pure nitrocellulose with a Hamilton syringe. The nitrocellulose is thoroughly dried between each application. The stain is purple on a white
background. The color developing reagent contains 5bromo-4-chloro-indolyl phosphate (BCIP) and nitroblue
tetrazolium (NBT). Total concentration = 2 mg/ml; a
= 0.5 µI; b = 0.3 µl; c = 0.2 µI.

Figure 2b (above). Isoelectric focusing. One µl of
standard ph 3-10 on right. Five µI aliquots of purified
protein on left (concentration 2 mg/ml). Arrow = 8.4.
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Isolation and purification

the aorta. The molecular weight of approximately 82 kD
on SDS PAGE is consistent with the result obtained on
AcA44 gel filtration, and the isoelectric point of 8.4,
classifying the protein as cationic, is compatible with the
high content of basic amino acids.
Partial sequencing of a peptide obtained after
cyanogen bromide cleavage of the protein necessitated
by a blocked N-terminal revealed approximately 60%
homology with CD59 (Protectin).
Immunodotting and
immunodiffusion with the CD59 monoclonal antibody
failed to detect the purified protein.
The sequence of the peptide generated from the
protein by cyanogen bromide cleavage follows:

Table 1. Percentage composition of
amino acids of cationic protein.
Aspartic Acid/ Aspargi ne
Threonine
Serine
Glutamic Acid/Glutamine
Isoleucine
Leucine
Tyrosine
Phenylanaline
Lysine
Histidine
Tryptophan
Arginine

of a shared protein

11.07
13.37
4.34
2.25
3.73
10.19
2.58
12.80
26.09
6.04

5
LEU-GLN-LEU-ASN-ASN-ARG

7.53

10

and the values read on a spectrophotometer at 280 nm.
Fraction II is pooled and dialyzed against large volumes
of distilled water in the cold room, followed by concentration against PEG to a volume of 5-10 ml. The concentrated fraction is mixed with a small volume of SI-17
(Pharmacia LKB, Piscataway, NJ) in 0.09 M Tris-Glycine buffer, allowed to stand for at least 2 hours and
centrifuged for removal of any pigment present. After
ultracentrifugation,
the protein containing peak is
chromatographed by fast protein liquid chromatography
(FPLC) on a polyanion SI-17 column (Pharmacia LKB).
Solution A is tris-glycine and solution B is tris-glycine
sodium chloride. The protein is eluted in the first peak
which is concentrated and dialyzed against distilled deionized water. The purity is checked by immunodiffusion, SDS polyacrylamide gel electrophoresis
(SDSPAGE) and immunoblotting.
The molecular weight was estimated by SDSPAGE (Figures la and lb) and gel filtration (calibration
kit; Pharmacia LKB); and the isoelectric point (Figure
2) was determined on agarose bound to a rigid support
(FMC Bioproducts, Rockland, ME). Amino acid analysis (Table 1) and amino acid sequencing (see Results),
immunodotting (Figure 3) and immunodiffusion were
also performed.
An Amplified Alkaline Phosphatase
Goat Anti-Rabbit Immuno Assay Kit (Bio-Rad, Chemical
Div., Richmond, CA) was used to assay the purified
protein and an Immuno-Blot Alkaline Phosphatase (Goat
Anti-Mouse, Bio-Rad) was employed to assay CD59
(monoclonal antibody, procured from Accurate Chemical
and Scientific Corporation, Westbury, NY). The Nterminal amino acid sequence was performed on a peptide generated by digestion of the protein with cyanogen
bromide and after separation of the peptides on a Vydac
Reverse Phase C 18 column (4.6 mm x 25 cm) (the analysis was carried out by O/T Biotechnology Research
Institute, Rockville, MD).

PRO-ASN-XXX-THR-ALA-ASP
15

GLU-L YS-THR-ALA

Discussion
The constant identity of the two proteins, one
extracted from stone and the other purified from urine,
as displayed by electrophoretic mobility and immunological activity, suggests that the procedure of extraction
preserves the native state of the protein. This would
give more credence to the in vitro studies of the role of
this and other similarly extracted proteins in the formation of urinary tract stones.
The cationic charge of the protein may be responsible for its presence in the stone through its linkage
with the anionic proteins, and once combined, could
form the elementary matrix ready to receive its first
cargo of salts if such are available in a supersaturated
solution.
The selective incorporation of the protein into
stones and its distribution in calcification prone sites
suggest a role for this protein in the process.
The partial homology with CD59 (Protectin)
would enlarge the distribution and role of an isoform of
this protein while the failure to react with a monoclonal
antibody to CD59 leaves the new protein without identification. Further research on the nature and role of this
interesting protein is being pursued.

Acknowledgements
We appreciate the assistance of the Veterans
Affairs Research Office and Research and Development
facility, and we wish to thank Dr. Nicholas Pomato,
Director of Biochemistry, O/T Biotechnology Research
Institute for his assistance with the sequence analysis.

Results

References

Scanning with the antiserum to proteins of the
urate-calcium oxalate stone revealed the presence of the
protein in bile, cholesterol gallstones and extracts from

I. Binette JP, Binette MB (1991). The matrix of
urinary tract stones: Protein composition, antigenicity
and ultrastructure. Scanning Microsc. 5, 1029-1036.

1109

J.P. Binette and M.B. Binette
2. Boyce WH, Sulkin NM (1956). Biocolloids of
urine in health and in calculous disease. III. The mucoprotein matrix of urinary calculi. J. Clin. Invest. 35:
1067-1079.
3. Grant AMS, Baker LRI, Neuberger H (1973).
Urinary Tamm-Horsfall glycoprotein in certain kidney
diseases and its content in renal and bladder calculi.
Clin. Science 44: 377-384.
4. Ingham KC (1990). Precipitation of protein.
In: Methods in Enzymology, Vol. 182. Deutscher MP
(ed.). Academic Press. p. 301-306.
5. Nakagawa Y, Ahmed MA, Hall SL, Deganello
S, Coe FL (1987). Isolation from human calcium oxalate
renal stones of nephrocalcin, a glycoprotein inhibitor of
calcium oxalate crystal growth. J. Clin. Invest. 79:
1782-1787.

Discussion with Reviewers
M.I. Resnick: Do the authors believe that the protein
is similar to proteins found in other stones such as pure
calcium oxalate struvite? What role will proteins play in
stones of this composition?
Authors: Yes, we believe that the protein is similar to
proteins found in other stones such as pure calcium
oxalate struvite. The role of the protein is speculative
at the present time. It is being studied, in vitro, by
physical chemical techniques.
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